Inhibition of poliovirus RNA synthesis as a molecular mechanism contributing to viral persistence in the mouse central nervous system.
Thérèse Couderc(Inserm), B Blondel(Nerve Centre), Stéphane Girard(Centre National de la Recherche Scientifique), Florence Colbère-Garapin(Institut Pasteur), D. Thiesson(Centre National de la Recherche Scientifique), Isabelle Pelletier(Institut Pasteur), J. Destombes(Centre National de la Recherche Scientifique)
PubMed
January 1, 2001
Cited by 6
Related Papers
A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease
|PLoS Pathogens|2008|610
Multidisciplinary Prospective Study of Mother-to-Child Chikungunya Virus Infections on the Island of La Réunion
|PLoS Medicine|2008|511
Chikungunya Virus-associated Long-term Arthralgia: A 36-month Prospective Longitudinal Study
|PLoS neglected tropical diseases|2013|494
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells
|The Journal of Experimental Medicine|2010|314
Prophylaxis and Therapy for Chikungunya Virus Infection
|The Journal of Infectious Diseases|2009|242